Gwendolyn Melnyk

Gwendolyn Melnyk

Vice President

New York Office  |   |   212.257.6039

Gwendolyn Melnyk, a Vice President at Torreya, specializes in North American strategic transactions.

Before joining Torreya in 2017, Gwen was an Associate in healthcare investment banking for Jefferies LLC working on sell- and buy-side M&A deals and debt and equity financings. Prior to Jefferies, she worked as a Research Associate for Regeneron Pharmaceuticals, Inc. and earlier as a Research and Development Associate for Cytimmune Sciences, Inc.

Gwen earned a B.A. in chemical and biomolecular engineering and an M.A. in biotechnology from John Hopkins University. She also earned an M.B.A. in finance and management from New York University.

Selected Transactions

Rockwell Medical
Exclusive license agreement to commercialize Triferic® in South Korea with
Jeil Pharmaceutical
September 2020
Sale of Noden to
Stanley Capital
Up to $52.83 Million
September 2020
License of NOV03
in North America to
Bausch Health
December 2019
Research collaboration and license agreement for
RIG-I pathway with
Up to $505 million
December 2018